Home

Habib J Dable

CIK 1690773 · CEO and President · last filed 2026-06-22

Habib J Dable is a CEO and President who has filed 43 SEC Form 4 insider transactions across 10 companies since 2016. The most recent filing, for PEPG, was dated Jun 22, 2026. Across all open-market trades the lifetime net is −$19.6M, making them a net seller over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

10

Total Filings

43

Lifetime Open-Market Net

-$19.55M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
PEPG Director — $2.41 — $0 5 2026-06-22
RLAY Director — $19.75 — $0 2 2026-06-10
Day One Biopharmaceuticals, Inc. (DAWN) Delisted Director — $21.53 — $0 5 2026-04-23
TYRA Director — $26.96 — $0 1 2026-04-20
SGP Director — $24.75 — $0 1 2026-02-09
Blueprint Medicines Corp (BPMC) Delisted Director 8,742 $129.46 $1.13M $0 5 2025-07-21
Jade Biosciences, Inc. (AVTE) Delisted Director — $93.80 — $0 4 2024-06-07
ALBIREO PHARMA, INC. (ALBO) Delisted Director — $44.15 — $0 2 2023-03-02
ACCELERON PHARMA INC (XLRN) Delisted CEO and President 0 $178.75 $0 -$19.55M 14 2021-11-22
Tempest Therapeutics, Inc. (MLND) Delisted Director — $15.90 — $0 4 2020-06-23

Recent Filings

43 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-22 PEPG Grant (A) — $0 EDGAR
2026-06-10 RLAY Grant (A) — $0 EDGAR
2026-04-23 Day One Biopharmaceuticals, Inc. (DAWN) Delisted Disp (D) — $0 EDGAR
2026-04-20 TYRA Grant (A) — $0 EDGAR
2026-02-09 SGP Grant (A) — $0 EDGAR
2025-11-07 Day One Biopharmaceuticals, Inc. (DAWN) Delisted Mixed — $0 EDGAR
2025-11-06 RLAY Grant (A) — $0 EDGAR
2025-07-21 Blueprint Medicines Corp (BPMC) Delisted Mixed −12,644 $0 EDGAR
2025-06-24 Blueprint Medicines Corp (BPMC) Delisted Grant (A) +3,902 $499.9K EDGAR
2025-06-06 PEPG Grant (A) — $0 EDGAR
Showing 1–10 of 43
Page 1 of 5
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.